• English
    • español
    • português (Brasil)
  • español 
    • English
    • español
    • português (Brasil)
  • Login
Ver ítem 
  •   COVID-19
  • Resources in English
  • Technical documents and research evidence on COVID-19
  • Ver ítem
  •   COVID-19
  • Resources in English
  • Technical documents and research evidence on COVID-19
  • Ver ítem
JavaScript is disabled for your browser. Some features of this site may not work without it.

Nucleoside inhibitors of Zika virus

 
Thumbnail
Fecha
2016
Autor
Eyer, Luděk
Nencka, Radim
Huvarová, Ivana
et al.
et al.
Metadatos
Mostrar el registro completo del ítem
Resumen
There is growing evidence that Zika virus (ZIKV) can cause devastating infant brain defects and other neurological disorders in humans. However, no specific antiviral therapy is available at present. We tested a series of 2′-C- or 2′-O-methyl–substituted nucleosides, 2′-C-fluoro-2′-C-methyl–substituted nucleosides, 3′-O-methyl–substituted nucleosides, 3′-deoxynucleosides, derivatives with 4′-C-azido substitution, heterobase-modified nucleosides, and neplanocins for their ability to inhibit ZIKV replication in cell culture. Antiviral activity was identified when 2′-C–methylated nucleosides were tested, suggesting that these compounds might represent promising lead candidates for further development of specific antivirals against ZIKV.
URI
There is growing evidence that Zika virus (ZIKV) can cause devastating infant brain defects and other neurological disorders in humans. However, no specific antiviral therapy is available at present. We tested a series of 2′-C- or 2′-O-methyl–substituted nucleosides, 2′-C-fluoro-2′-C-methyl–substituted nucleosides, 3′-O-methyl–substituted nucleosides, 3′-deoxynucleosides, derivatives with 4′-C-azido substitution, heterobase-modified nucleosides, and neplanocins for their ability to inhibit ZIKV replication in cell culture. Antiviral activity was identified when 2′-C–methylated nucleosides were tested, suggesting that these compounds might represent promising lead candidates for further development of specific antivirals against ZIKV.
Colecciones
  • Technical documents and research evidence on COVID-19

Lista

TodoComunidades & ColeccionesPor fecha de publicaciónAutoresTítulosCategoríaMateriasEsta colecciónPor fecha de publicaciónAutoresTítulosCategoríaMaterias

Mi cuenta

AccederRegistro

Organización Panamericana de la Salud
Organización Mundial de la Salud. Oficina Regional para las Américas
525 Twenty-third Street, N.W., Washington, D.C. 20037, Estados Unidos de América

Notas importantes sobre el material (Disclaimer)

Links

  • OMS Brote de enfermedad por coronavirus
  • OPS Enfermedad por el Coronavirus
  • OPS/BIREME Vitrina de Conocimiento COVID-19

  • Biblioteca Digital de la OPS (IRIS PAHO)
  • Biblioteca Virtual en Salud (BVS)
  • Global Index Medicus (GIM)